$CoreWeave Fell 12%, But the Bond Market Said It First: Will the Credit Warning Spread? A Put Seller's Read

Written Monday 19 Oct, SGT, using Friday's US closes.

Most people saw the headline: CoreWeave down 11.91% on Friday to $61.39. But the stock was the last thing to move. The bond market had been warning about this for weeks.

What actually happened

- Stock: down 25.21% for the week, from $82.08 to $61.39, just above its 52-week low of $59.51. It is down 55.91% over the past year.

- Bonds: the October 2031 notes briefly yielded more than 16% on Thursday, and some CoreWeave bonds traded near 79 cents on the dollar.

- Credit default swaps: the five-year CDS hit an all-time intraday high of 1,194.5 basis points and closed Friday at 1,117. Bloomberg data puts the implied probability of default over five years at more than 60%.

- Contagion: Nebius fell by double digits on Friday, while IREN and Applied Digital each dropped about 9%.

Bonds and CDS are where professional credit investors place their bets. When insurance on a company's debt costs more than 11% a year, they're saying the equity story has a funding problem.

The balance sheet in numbers

This is the part the headline leaves out.

- Total debt: $51.61 billion

- Cash and equivalents: $5.54 billion

- Market capitalization: about $33.86 billion. The company owes more than the stock market says it's worth.

- Q2 interest expense: $640 million, up from $267 million a year earlier

- Q2 adjusted operating income: $128 million. The interest bill was five times the operating profit.

- Q3 interest guidance: $860 to $940 million, about a quarter of the $3.45 to $3.6 billion revenue guidance

- Q2 free cash flow: negative $5.74 billion

- 2026 capex guidance: $35 to $39 billion, funded by debt and equity raises

Add the rate backdrop. CPI and PPI both came in hot last week, CME pricing shows 74.3% odds of a December hike, and the 10-year yield sits near 5.1%. When a company depends on new borrowing to grow, every hike makes the next round of funding more expensive.

The founder sales

The three co-founders have sold about $3.3 billion of stock since the March 2025 IPO, $2.4 billion of it in 2026:

- Brian Venturo: more than $1.2 billion, including $734 million in Q2 alone

- Brannin McBee: $1.06 billion, about 40% of his IPO holding

- CEO Michael Intrator: more than $907 million since Jan 1, 2026, compared with under $70 million in all of 2025

The company says the sales are pre-scheduled and fully disclosed, and the founders still own about 20% combined. That's fair. But when insiders accelerate selling at the same time the company is borrowing record amounts, the market reads it as a signal, whatever the paperwork says.

The bull case deserves a fair hearing

- Backlog: $104 billion at the end of Q2, up 246% year over year, plus more than $25 billion in new commitments signed early in Q3.

- Demand: Cantor Fitzgerald kept its Overweight rating and $176 target. It says nearly all 2027 capacity is sold out and that the payback period on AI chips has shortened to 2 to 2.5 years.

- Nvidia: it owns about 10% of CoreWeave, and Jensen Huang has said CoreWeave's financial strength is "improving every day".

- Buyers stepped in: retail investors bought a net $66 million that week, and ARK funds added more than 381,000 shares.

- Evercore kept its Outperform rating, arguing the bond market is extrapolating a single selloff.

So this isn't a demand problem. Customers want the GPUs. The question is whether CoreWeave can fund the buildout before the contracts turn into cash, at a time when borrowing costs are rising.

Will the credit warning spread?

There are three channels to watch.

1. Other neoclouds. Nebius, IREN and Applied Digital all run similar models: heavy capex, borrowed money, contracted demand. Friday's sympathy selling shows the market already treats them as one trade.

2. Nvidia. CoreWeave is a major GPU buyer and Nvidia owns about 10% of it. A neocloud that can't raise money can't place orders. So far the market isn't pricing this in heavily: Nvidia fell only 1.43% on Friday and was trading higher in Monday's pre-market.

3. The lenders. Most AI infrastructure debt is asset-backed and tied to contracts, which offers some protection. But if CDS stays above 1,000bp, refinancing gets more expensive for the whole group, not just CoreWeave.

What I'm tracking each week:

- Whether CoreWeave CDS goes back below 1,000bp or pushes past the 1,194.5bp high

- The 2031 bond yield relative to 16%

- Whether Nebius and IREN move with CoreWeave or start to separate from it

- Hyperscaler capex: Meta reports Oct 21, Microsoft and Alphabet Oct 28

- CoreWeave's Q3 report, expected around Nov 9 but not yet confirmed by the company. The key number is whether interest expense lands inside the $860 to $940 million guidance.

To answer the topic directly: track CoreWeave's orders and Nvidia's demand to judge who wins the customers. Favor the cash-generating platforms when you want to know who survives the funding cycle. Right now the market is asking the second question.

How I apply my sell-put strategy here

CoreWeave was my main sell-put vehicle in the second quarter, so I'm not writing this as an outsider. Here's why it's a hard no today.

1. It fails the 200-day SMA gate.

The stock is around $61, and its 200-day moving average is around $92, roughly 34% below. My hard rule is no puts on stocks below the 200-day. This gate alone ends the discussion.

2. It's blocked by the earnings calendar.

The Q3 report is expected around Nov 9. My standard 30 to 45 day expiries run from roughly Nov 18 to Dec 3, so every one of them straddles the report. I don't hold earnings inside an expiry.

3. A credit warning means the premium is a disguised credit bet.

After a 25% weekly drop, CoreWeave puts will pay a lot. But when CDS trades above 1,000bp, that premium is mostly the market charging for default risk. Selling a put here means writing credit insurance on a company the bond market already prices as distressed. I'm not paid enough for that.

4. Check for contagion before touching related names.

Nvidia is my core name, but its report is expected around Nov 17 (not yet confirmed), which blocks it on the calendar too. Nebius has to pass the same structure and credit checks on its own.

5. My re-entry checklist. All three must be true:

- CDS back under 1,000bp

- Price reclaims and holds the 200-day moving average

5. My re-entry checklist. All three must be true:

- CDS back under 1,000bp

- Price reclaims and holds the 200-day moving average

- The Q3 report is out and the guidance holds

Only then do I run the normal gates: IV Rank at least 40%, IV Percentile at least 45%, IV at least 1.2 times historical volatility, the strike at the lower of the one standard deviation floor or the moving average x 0.98, delta between 0.15 and 0.25, and position size capped at 2% for non-core names. The exits are set on day one: a 50% take-profit GTC, a stop at 2.5x premium, and one roll at most.

6. In a credit scare, quality comes first.

When funding gets tight, I'd rather sell puts on companies that pay for their capex out of operating cash flow and carry investment-grade balance sheets, once they pass the earnings blackout.

My plan

No new CoreWeave or neocloud puts. I'll watch the CDS and not the bounce. A stock can rally 2% in pre-market while the credit market is still pricing default. When the bond market calms down, the stock will tell me, and my gates will confirm it.

Your turn: is CoreWeave a funding problem that more backlog will fix, or the first crack in AI infrastructure credit? And which number are you watching most: the CDS, the 2031 bond, or Nvidia's next guide?

This is my personal trading framework, shared for education. It is not investment advice. Options carry significant risk, including assignment and losses larger than the premium collected. Always verify live chain data and confirmed earnings dates before trading.

$CRWV $NVDA $NBIS $MSFT